Atlas Trials

Professor Francois Venter

6 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Professor Francois Venter

RecordFirmDate
A Randomised, Phase 3 Non-inferiority Study of DOR/3TC/TDF Compared to DTG/TAF/FTC in Participants Infected With HIV-1 Starting First-line Antiretroviral Therapy (NCT05924438)Professor Francois Venter2023-11-08
Utilizing Private Pharmacies to Initiate High-risk Young Individuals on PrEP in South Africa (NCT07006246)Professor Francois Venter2023-05-19
ADORE: Efficacy of DORavirine in Adults Living With HIV Experiencing Virological Failure on First-line Efavirenz-based Antiretroviral Therapy With NNRTI Resistance (NCT04429152)Professor Francois Venter2021-02-09
DORA: A Doravirine-based First-line Antiretroviral Therapy for Women of Reproductive Potential Living With HIV (NCT04433780)Professor Francois Venter2021-01-04
The Effect of Rifampicin on the Pharmacokinetics of Intracellular Tenofovir-diphosphate and Tenofovir When Coadministered With Tenofovir Alafenamide Fumarate During the Maintenance Phase of Tuberculosis Treatment in TB/HIV-1 Coinfected Participants (NCT04424264)Professor Francois Venter2019-12-05

Track Professor Francois Venter automatically

Every clearance here is in the API, with alerts when new ones post.